Press Release / Media Release
Zydus receives final approval from the USFDA for Indomethacin Extended-Release Capsules USP27-09-2017
27-09-2017
Zydus Cadila gets USFDA nod to sell hypertension drug
The group has now more than 150 approvals and has so far filed over 300 abbreviated new drug applications23-09-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Amlodipine and Olmesartan Medoxomil Tablets23-09-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Itraconazole Capsules 100 mg.21-09-2017
Zydus Cadila gets final FDA nod for skin disorder, hypertension drugs
While Desoximetasone ointment is used for treatment of symptoms of a skin disease, Labetalol hydrochloride tablets are used for the treatment of high blood pressure20-09-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Desoximetasone Ointment and Labetalol Hydrochloride Tablets20-09-2017
Press Release / Media Release
Zydus and Pharm Aid Ltd., enter into an exclusive agreement for vaccine technology in Russia.19-09-2017
Press Release / Media Release
Zydus' Nesher Pharmaceuticals gets USFDA final approval for Oseltamivir Powder for Oral Suspension'16-09-2017
Zydus gets two product approvals from USFDA
Cadila Healthcare Ltd (Zydus Cadila) on Friday announced that the company has received final approval from the US drug regulator US Food and Drug Administration (USFDA) to market Modafinil tablets...15-09-2017